ClinicalTrials.Veeva

Menu
B

Brooke Army Medical Center | Hepatology Gastroenterology Clinic

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Paclitaxel
Cisplatin
Bevacizumab
Gemcitabine
Carboplatin
Cyclophosphamide
cyclophosphamide
cisplatin
doxorubicin hydrochloride
Doxorubicin Hydrochloride
0

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 304 total trials

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337

A double-blind placebo controlled randomized Phase 3 study to determine if 80 or 100 mg of MGL-3196 as compared with placebo resolves NASH and/or red...

Active, not recruiting
NASH - Nonalcoholic Steatohepatitis
Procedure: Liver Biopsy
Drug: MGL-3196

The purpose of this study is to compare the efficacy of teclistamab with PVd/Kd.

Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Dexamethasone
Drug: Pomalidomide

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cance...

Enrolling
Breast Neoplasms
Drug: Anastrozole
Drug: Tamoxifen

The purpose of this study is to assess if adding LY3537982 in combination with standard of care anti-cancer drugs is more effective than standard of...

Enrolling
Carcinoma, Non-Small-Cell Lung
Neoplasm Metastasis
Drug: Carboplatin
Drug: Pemetrexed

The proposed study will be a prospective trial of management of acute traumatic wounds (less than 24 hours from injury and without previous intervent...

Not yet enrolling
Acute Wound
Device: Antimicrobial Wound Gel (AWG)
Device: Antimicrobial Skin & Wound Cleanser (AWC)

This is a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group, large simple trial to investigate the efficacy and...

Enrolling
Traumatic Injury
Drug: BE1116
Drug: Placebo

This randomized, controlled, pivotal study is intended to determine whether up to ten sequential 24-hour treatments with the Selective Cytopheretic D...

Enrolling
Acute Kidney Injury
Device: Selective Cytopheretic Device
Other: Standard of Care

The goal of this comparative pilot study is to provide evidence that Praxis, a portable testbed with low-cost wearable sensors and a mixed reality en...

Invitation-only
Cognition Disorder
Mild Traumatic Brain Injury
Device: Praxis
Behavioral: Supervised cardiovascular exercise

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and...

Active, not recruiting
Colorectal Neoplasms
Drug: Eflornithine placebo & sulindac placebo
Drug: Eflornithine plus sulindac

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) who have previously received treatment with...

Active, not recruiting
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Idelalisib
Drug: Bendamustine

Trial sponsors

SWOG Cancer Research Network logo
National Cancer Institute (NCI) logo
C
Brooke Army Medical Center logo
G
R
Alliance for Clinical Trials in Oncology logo
E
Gilead Sciences logo
The University of Texas System (UT) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems